Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05659914 |
|---|---|
| Brief Title: | Olaparib and Durvalumab (MEDI4736) in Patients With Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations |
| First Submitted : | November 22, 2022 |
| First Submitted that Met QC Criteria : | December 13, 2022 |
| First Posted : | December 21, 2022 |
| Last Update Submitted that Met QC Criteria : | December 27, 2023 |
| Last Update Posted : | December 28, 2023 |